Accendra Health, Inc. announced on October 29, 2026, that it has executed an amendment to its Receivables Purchase Agreement. The filing details the agreement between Accendra Funding LLC, a wholly-owned subsidiary of Accendra Health, and Byram Healthcare Centers, Inc., another subsidiary of the company. The amendment modifies the Amended & Restated Receivables Purchase Agreement, originally dated December 31, 2025, which governs the sale of receivables.
The primary change disclosed in the filing is the extension of the Scheduled Termination Date for the facility. The agreement now extends until October 2029, replacing the previous end date. The size of the program remains unchanged at $150 million. The amendment also updates account control provisions and reporting obligations under the agreement.
PNC Bank, National Association serves as the Administrative Agent and Structuring Agent for the transaction. The filing notes that PNC has various ongoing relationships with the company and its subsidiaries, including investment banking and commercial banking services, for which customary fees are paid. The amendment is summarized in Item 1.01 of the current report.
Accendra Health also furnished a press release dated November 2, 2026, regarding the amendment. The press release quotes Executive Vice President and Chief Financial Officer Jonathan Leon, who stated that the extension ensures the company’s liquidity strength and reflects the strength of its accounts receivable portfolio and processes.
